Antihyperglycemic and antihyperlipidemic effects of hydro-methanolic extract of seed of Caesalpinia bonduc in streptozotocin induced diabetic male albino rat

International Journal of PharmTech Research

Volumn 2, Issue 4, 2010, Pages 2234-2242

  Jana, Kishalay ^a   Chatterjee, Kausik ^a   Bera, Tushar Kanti ^a,b   Maiti, Soumyajit ^a   De, Debasis ^a   Ali, Kazi Monjur ^a   Ghosh, Debidas ^a  

^a VIDYASAGAR UNIVERSITY   (India)

^b Southern Health Improvement Samity (SHIS)   (India)

Author keywords

Caesalpinia bonduc; Carbohydrate metabolic enzymes; Glycogen; Hyperlipidemia; Transaminases enzymes

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; CAESALPINIA BONDUC EXTRACT; CARBOHYDRATE; GLIBENCLAMIDE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOGEN; HEXOKINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERGLYCEMIC ACTIVITY; ANTIHYPERLIPIDEMIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CAESALPINIA BONDUC; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLYCOGEN MUSCLE LEVEL; MALE; MEDICINAL PLANT; NONHUMAN; PLANT SEED; RAT; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 78249240864     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. th edn, Tata McGraw Hill, 1998, 2081-20.
2. Wild S. G. Folic A. Green R. King H., Global prevalence of diabetes. Estimated for the year 2000 and projection for 2030, Diabetes Care., 2004, 27, 1047-1054.
3. Lyra R. M. Oliveira D. L. Cavalcanti N., Prevention of type 2 diabetes mellitus, Arq. Bras. Endocrinol. Metabo., 2006, 50, 239-249.
4. Morel D. W. and. Chisolm G. M., Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity, J. Lipid Res., 1989, 30, 1827-1834.
5. th edn., Appleton and Lange, Connecticut, USA, 1996, 586-587.
6. th edn, Department of Health and Human Services, Public Health Service, National Institutes of Health, Washington DC, DHHS, 1995, 95-1468.
7. Shukla R. S. B. Sharma D. Puri K. M. Murthy P. S., Medicinal plants for treatment of diabetes mellitus, Ind. J. Clin. Biochem., 2000, 15, 169-177.
8. Mahomed I. M. and Ojewole J. A., Hypoglycemic effect of Hypoxis hemerocallidea corm (African potato) aqueous extract in rats, Method Find. Exp. Clin. Pharmacol., 2003, 25, 617-623.
9. Hou Z. Zhang Z. Wu H., Effect of Sanguis draxonis (a Chinese traditional herb) on the formation of insulin resistance in rats, Diabetes Res. Clin. Pract., 2005, 68, 3-11.
10. Ali K. M. Chatterjee K. De D. Bera T. K. Mallick C. Ghosh D., Hypoglycemic, antioxidant and antihyperlipidemic effects of aqueous extract of sepals of Salmalia malabarica in Streptozotocin-induced diabetic rat, Ethiop. Pharm. J., 2009a, 27, 1-15.
11. Sellamuthu P. S. Muniappan B. P. Perumal S. M. Kandasami M., Antihyperglycemic effect of Mangiferin in Streptozotocin Induced Diabetic Rats, J. Health Sci., 2009, 55, 206-214.
12. Loew D. and Kaszkin M., Approaching the problem of bioequivalence of herbal medicinal products, Phytother. Res., 2002, 16, 705-711.
13. Gaur R. L., Sahoo M. K. Dixit S. Fatma N. Rastogi S. Kulshreshtha D. K. Chatterjee R. K. Murthy P. K., Antifilarial activity of Caesalpinia bonducella against experimental filarial infections, Ind. J. Med. Res., 2008, 128, 65-70.
14. Chakrabarti S. Biswas T. K. Rokeya B. Ali L. Mosihuzzaman M. Nahar N. Khan A. K. Mukherjee B., Advanced studies on the hypoglycemic effect of Caesalpinia bonducella F. in type 1 and 2 diabetes in Long Evans rats, J. Ethnopharmacol., 2003, 84, 41-46.
15. Mallick C. Chatterjee K. Mandal U. Ghosh D., Antihyperglycemic, antilipidperoxidative and antioxidative effects of Musa paradisiaca and Coccinia indica in streptozotocin-induced diabetic rat, Ethiop. Pharm. J., 2007, 25, 9-22.
16. Ali K. M. Chatterjee K. De D. Bera T. K. Ghosh D., Efficacy of aqueous extract of seed of Holarrhena antidysenterica for the management of diabetes in experimental model rat: A correlative study with antihyperlipidemic activity, Int. J. Appl. Res. Nat. Prod., 2009b, 2, 13-21.
17. Chou A. C. Wilson J. E., Carbohydrate metabolism. In: Wood WA, (ed.) Methods in Enzymol. Vol. XIII. New York, Academic Press, 1975, 20-21.
18. Langdon R. G., Glucose-6-phosphate dehydrogenase from erythrocytes. In: Wood WA, (ed.) Methods in Enzymol. Vol. IX. New York, Academic Press, 1966, 126-131.
19. Swanson M. A., Glucose-6-phosphatase from liver. In: Colowick, S. P. Kaplan N. O. (eds.) Methods in Enzymes. Vol. II. New York, Academic Press, 1955, 541-543.
20. rd edn, New Delhi., 2008, 9-10.
21. Mandal S. Barik B. Mallick C. De D. Ghosh D., Therapeutic effect of ferulic acid, an ethereal fraction of ethanolic extract of seed of Syzygium cumini against streptozotocin-induced diabetes in male rat, Method Find. Exp. Clin. Pharmacol., 2008, 30, 121-128.
22. Desai S. A. Mani U. V. Lyer U. M., Serum lipids, apolipoproteins and total antioxidant activity levels of obese, diabetic and hypertensive subjects in an industrial set up in Baroda, Gujarat, India, Int. J. Diab. Dev. Countries., 2002, 22, 91-99.
23. Allain C. C. Poon L. S. Chan C. S. G., Enzymatic determination of total serum cholesterol, Clin. Chem., 1974, 20, 470-475.
24. Friedewald W. T. Levy K. J. Frederickson D. S., Estimation of concentration of LDL in plasma without of preparative ultracentrifuge, Clin. Chem., 1972, 18, 499-502.
25. Waenic R. G. and Albers J. J., A comprehensive evaluation of the heparin manganease precipitation procedure for estimating high density lipoprotein cholesterol, J. Lipid. Res., 1978, 19, 65-76.
26. Henry R. J. Chiamori M. Gonub O. J. Berkman S., Revised spectrophotometric methods for the determination of glutamate oxaloacetic transaminase, glutamate pyruvate transaminase and lactic acid dehydrogenase, Am. J. Clin. Pathol., 1960, 34, 381-398.
27. Sokal R. R. and Rohle F. J., Introduction to Analysiy of Variance, In: Biometry, WH, Freeman and Company, New York, 1997, 179-206.
28. Cooperstin S. J. and Watkin D., Action of Toxic Drugs on Islet Cells. In the Islets of Langerhans, Academic Press, New York, 1981, 387-425.
29. Carter A. C. Broder L. Friedman M., Streptozotocin and metastatic insulinoma, Ann. Intern. Med., 1971, 74, 445-446.
30. Chauhan S. Nath N. Tule V., Antidiabetic and antioxidant effects of Picrorhiza kurrooa rhizome extracts in diabetic rats, Ind. J. Clin. Biochem., 2008, 23, 238-242.
31. Bera T. K. De D. Chatterjee K. Ali K. M. Ghosh D., Effect of Diashis, a polyherbal formulation, in streptozotocin-induced diabetic male albino rats, Int. J. Ayurveda Res., 2010, 1, 18-24.
32. Betterridge J., Lipid disorders in diabetes mellitus. In: Pickup J and Williams G. (eds.) Textbook of Diabetes. Blackwell Science, London, 2002, 551-553.
33. Maiti R. Das U. K. Ghosh D., Attenuation of hyperglycemia and hyperlipidemia in streptozotocin induced diabetic rats by aqueous extract of seed of Tamarindus indica, Biol. Pharma. Bull., 2005, 28, 1172-1176.
34. Yadav J. P. Saini S. Kalia A. N. and Dangi A. S., Hypoglycemic and hypolipidemic activity of ethanolic extract of Salvadora oleoides in normal and alloxaninduced diabetic rats, Ind. J. Pharmacol., 2008, 40, 23-27.
35. Chattopadhyay R. R. and Bandyopadhyay M., Effect of Azadirachta indica on serum lipid profile changes in normal and streptozotocin induced diabetic rats, Afr. J. Biomed. Res., 2005, 8, 101-104.
36. McAnuff M. A. Omoruyi F. O. Morrison E. Y. Asemota H. N., Hepatic function enzymes and lipid peroxidation in streptozotocin induced diabetic rats fed bitter yam (Dioscorea polygonoides) steroidal sapogenin extract, Diabetologia Croatica., 2003, 32, 17-22.
37. Akther M. H. Mathur M. and Vhide N. K., Skin and liver toxicity in experimental Lantanc camara poisoning in albino rats., Ind. J. physiol. pharmacol., 1990, 34, 13-16.